The UK Medical and Healthcare products Regulatory Agency (MHRA) has granted approval for Cybin to initiate the randomised ...

People with anxiety or depression show distinct patterns in their gut bacteria, and commonly prescribed psychiatric ...

The most prevalent symptom of discontinuation was dizziness, and, despite being measured in people with major depressive disorder, discontinuation was not associated with depression symptoms.

Screening positively for major depressive disorder and higher anxiety levels may not impact functional outcomes in patients ...

Out of 64 supplements, only 4 are considered safe and effective for treating depression, according to new research.

FDA reviewers flag "discordant results" in a briefing document published ahead of Friday's advisory committee meeting for the ...

The CAPS-5 total score ranks severity of 20 PTSD symptoms from 0 (not present) to 80 (most severe). Baseline values for the ...

The magic mushroom compound psilocybin shows long-lasting antidepressant effects in a clinical trial, with patients reporting ...

Major depressive disorder impacts peripheral artery disease risk through intermediary risk factors. J Am Heart Assoc . 2024 Feb 20;13(4):e030233. doi: 10.1161/JAHA.123.030233. Epub 2024 Feb 16.

Previous research showed that the prevalence of major depressive disorder among adolescents nearly doubled recently, rising to 15.8 percent in 2019 from 8.1 percent in 2009.

More than 7 million people in the United States live with Alzheimer's disease and related dementia (ADRD). Some risk factors ...

Major Depressive Disorder pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as.